Revia in Canada: Naltrexone Treatment Information and Pharmacy Ordering

Understanding Revia

Revia is a brand name associated with naltrexone hydrochloride, a medicine used in the management of alcohol dependence and opioid dependence. It is not an opioid and does not produce the euphoric or sedating effects associated with opioid medicines. Treatment should be planned with a qualified prescriber and supported by appropriate medical and psychosocial care.

Naltrexone works best as one component of a broader recovery plan rather than as a stand-alone solution. Its role is to reduce the reinforcing effects of alcohol or opioids in suitable patients. Individual outcomes depend on diagnosis, adherence, counselling support, physical health, and ongoing clinical review.

Brand availability can change over time in Canada, and some pharmacies may supply generic naltrexone rather than a product labelled Revia. A pharmacist can help confirm the active ingredient, strength, manufacturer, and current stock before dispensing. Never substitute a medicine solely on the basis of a similar-sounding name.

Active Ingredient and Medicine Class

The active ingredient in Revia is naltrexone hydrochloride. It belongs to a group of medicines called opioid antagonists, meaning that it attaches to opioid receptors and blocks them. This receptor activity is central to its use in alcohol-use disorder and opioid-use disorder.

Naltrexone is different from opioid replacement treatments because it does not activate opioid receptors. Taking it while opioids remain in the body can trigger sudden, severe withdrawal symptoms. For this reason, prescribers need an accurate account of recent opioid use, including pain medicines, cough products, and non-prescribed substances.

The tablet formulation is generally taken by mouth and absorbed into the bloodstream before being processed mainly by the liver. Its principal metabolite also has opioid-blocking activity. Liver function and concurrent medicines may therefore be relevant to safe treatment selection.

What Revia Is Used For

Revia may be prescribed to help people with alcohol dependence reduce alcohol reward, cravings, or heavy-drinking patterns. It does not make alcohol physically unsafe in the way that certain alcohol-deterrent medicines can. Continuing to drink may still cause serious health, safety, and social consequences.

It may also be used after medically supervised opioid withdrawal to support relapse prevention. Before starting, the patient must be opioid-free for an appropriate interval determined by the prescriber. The required interval varies with the opioid involved, the duration of use, and the person’s clinical circumstances.

Revia is not intended for treating acute opioid withdrawal or for relieving opioid pain. It will block the effect of opioid analgesics and can complicate emergency pain management. Patients should tell clinicians, dentists, and emergency personnel that they take or recently took naltrexone.

Origin and Development of Naltrexone

Naltrexone was developed during research into compounds that could block opioid receptor activity. It emerged after earlier opioid antagonists demonstrated that receptor blockade could have therapeutic uses. Researchers sought an orally active medicine with a longer duration of action than some earlier options.

Its development reflected growing understanding of how opioid receptors influence reward, reinforcement, and relapse. Clinical use later expanded from opioid-dependence care to alcohol-use disorder treatment. That expansion was based on the observation that endogenous opioid pathways can contribute to alcohol’s rewarding effects for some people.

Modern use of naltrexone is guided by clinical assessment rather than a one-size-fits-all approach. It may be appropriate for some patients and unsuitable for others, particularly those using opioids or with significant liver concerns. Current prescribing decisions should rely on Canadian product information and professional judgement.

How Revia Works in the Body

Revia occupies opioid receptors, especially mu-opioid receptors, without activating them in the usual opioid-like manner. This reduces or prevents the effects of opioid medicines and illicit opioids. It can also reduce the rewarding response that contributes to alcohol use in some individuals.

Because receptor blockade is competitive, attempts to overcome it by taking larger amounts of opioids are dangerous. As naltrexone levels decline, a person may be vulnerable to overdose if they return to an opioid dose previously tolerated. Opioid tolerance can fall during abstinence, increasing this risk substantially.

The medicine does not cure addiction or remove the need for behavioural support. It is usually considered alongside counselling, recovery programs, monitoring, and treatment of co-occurring mental or physical health conditions. A prescriber can explain realistic goals for a specific treatment plan.

How to Take Revia Safely

Take Revia exactly as prescribed and follow the directions on the dispensing label. It may be taken with food if stomach upset occurs, unless the prescriber gives different instructions. Do not change the dose, stop treatment, or restart it after a break without clinical advice.

Before the first dose, disclose every opioid-containing product used recently. This includes prescribed pain medicines, opioid substitution therapy, certain cough or diarrhoea products, and non-prescribed drugs. A clinician may use history, examination, testing, or a supervised challenge when appropriate to reduce the risk of precipitated withdrawal.

If a dose is missed, follow the instructions provided by the prescriber or pharmacist. Do not take an extra dose to compensate unless specifically told to do so. Contact a pharmacy professional if there is uncertainty about missed doses, vomiting after a dose, or an unexpected change in symptoms.

Forms and Common Strengths

Revia has commonly been supplied as oral naltrexone tablets, often in a 50 mg strength. The exact brand, tablet appearance, and package size can vary by manufacturer and market availability. Your dispensed package and pharmacy label are the reliable sources for the product you receive.

Long-acting injectable naltrexone exists in some markets, but it is a different formulation and may have different brand availability in Canada. It should not be considered interchangeable with oral tablets without a prescriber’s direction. Administration, monitoring, access, and coverage arrangements can differ between formulations.

A clinician may select a regimen based on the treatment indication, medical history, liver status, opioid exposure, and ability to attend follow-up. Tablet treatment allows dosing to be stopped relatively quickly when medically necessary. It also requires consistent adherence for the intended benefit.

Prescription Requirements in Canada

Revia and generic naltrexone are prescription medicines in Canada. A legitimate pharmacy requires a valid prescription from an authorized Canadian prescriber before dispensing. Claims that this medicine is available without prescription should be treated as a serious safety and legal warning sign.

Prescription review matters because undetected opioid use can make starting naltrexone medically dangerous. The prescriber also needs to assess liver history, other medicines, pregnancy considerations, and the treatment objective. These checks are part of responsible care, not unnecessary barriers.

An online pharmacy should clearly identify its licensing information, provide access to a pharmacist, and request appropriate prescription documentation. Patients may also ask their provincial or territorial pharmacy regulator how to verify a pharmacy. Avoid websites that conceal their location, promise unrestricted supply, or skip clinical screening.

Ordering Revia Through Our Pharmacy

To order Revia through our pharmacy, begin by submitting a valid prescription using the secure process provided at checkout or by arranging a prescriber-to-pharmacy transfer. The pharmacy team reviews the prescription, patient details, and potential dispensing issues before processing. If clarification is needed, the team may contact the prescriber or patient before shipment.

Patients should provide current contact details and disclose relevant medicines during the pharmacy review. This helps the pharmacist identify potential opioid exposure, duplications, or interactions requiring follow-up. Confidential health information should be handled through secure channels rather than ordinary social-media messaging.

Where dispensing is appropriate, the pharmacy confirms the product, quantity, delivery options, and applicable charges before fulfilment. Availability depends on authorized supply and prescription validity. A pharmacist remains an important source of medicine-specific counselling before and after purchase.

Typical Pharmacy Price Considerations

The price of naltrexone tablets can vary among Canadian pharmacies because of manufacturer, quantity prescribed, dispensing fees, delivery charges, and insurance arrangements. Generic naltrexone may be less costly than a branded product when both are available. A pharmacy can provide a current quote before dispensing rather than relying on outdated comparisons.

As a general comparison, costs in other online pharmacies may differ between a short supply and a longer prescription quantity. Provincial drug plans, private insurance, and clinic-based programs may affect the patient’s final out-of-pocket amount. Coverage rules should be checked directly with the insurer or benefits administrator.

Low advertised pricing should not outweigh pharmacy verification and clinical safeguards. Confirm whether the quote includes the medicine, pharmacist dispensing fee, shipping, taxes where applicable, and any required consultation. A transparent total is more useful than an incomplete headline amount.

How Long Revia Stays in the Body

Naltrexone itself has a relatively short plasma half-life, while its active metabolite can remain longer. In broad terms, the medicine and its metabolites may take several days to clear substantially after the final tablet dose. Clearance varies with liver function, dose pattern, age, and individual metabolism.

Laboratory detectability and clinical effect are not the same thing. A medicine may be measurable after its most noticeable receptor-blocking effect has decreased, and different tests have different detection windows. Only a clinician can interpret timing questions in the context of treatment, toxicology, or planned pain care.

Patients considering opioid pain treatment, surgery, or a change in addiction treatment should not estimate clearance on their own. The care team needs to know the date and amount of the last dose. Planned procedures may require a coordinated approach involving the prescriber, surgeon, anaesthetist, and pharmacist.

Duration of Effect

A usual oral dose of naltrexone can provide clinically meaningful opioid-receptor blockade for approximately a day, although the duration varies between people. This is one reason daily dosing is commonly used. The effect should not be interpreted as a guarantee of protection against opioid overdose or relapse.

The effect on alcohol cravings or drinking patterns is less immediate and differs from person to person. Some patients notice changes over time as medication is combined with behavioural strategies and follow-up. Others may not benefit sufficiently or may experience adverse effects that require a different plan.

Do not test the medicine’s blocking effect by using opioids. Doing so can lead to poisoning, delayed overdose, or severe complications when the blockade wanes. Seek urgent medical assistance for suspected opioid exposure, overdose symptoms, or breathing difficulty.

Scientific Evidence and Clinical Role

Clinical research supports naltrexone as one evidence-based treatment option for alcohol-use disorder and for relapse prevention following opioid detoxification. Its benefit is usually evaluated through patient-centred outcomes such as reduced heavy drinking, improved ability to maintain goals, or reduced opioid use. Response is variable, so ongoing assessment is important.

Studies and guidelines generally place medication alongside psychosocial support rather than in opposition to it. Counselling, peer support, treatment for anxiety or depression, and practical relapse-prevention planning can all be relevant. The most appropriate combination depends on the individual’s needs and preferences.

Evidence does not mean that a medicine is right for every patient. Active opioid use, inability to complete withdrawal, serious liver disease, or intolerance may change the balance of benefits and risks. A prescriber should reassess treatment when goals, symptoms, or medical circumstances change.

Dependence, Addiction, and Misuse

Revia is not considered addictive and does not usually cause physical dependence. It does not create an opioid-like high because it blocks rather than stimulates opioid receptors. Stopping it does not typically produce a classic withdrawal syndrome caused by the medicine itself.

However, discontinuing naltrexone can remove opioid blockade and may leave a person at increased overdose risk if opioid use resumes. Tolerance may be lower after a period without opioids. This makes education, overdose-prevention planning, and access to emergency support particularly important.

Medication treatment should not be confused with a complete resolution of substance-use disorder. Relapse can occur, and it should prompt timely, non-judgmental clinical support rather than self-directed dose changes. Patients and families may wish to discuss naloxone access and emergency response planning with a healthcare professional.

Alternatives to Revia

Alternatives depend on whether treatment is for alcohol-use disorder or opioid-use disorder. For alcohol-use disorder, clinicians may consider medicines such as acamprosate or disulfiram in selected circumstances, alongside non-medication approaches. Suitability depends on health conditions, drinking goals, adherence, and potential contraindications.

For opioid-use disorder, opioid agonist therapies such as buprenorphine-based treatment or methadone may be more appropriate for many patients. These therapies have a different mechanism and require their own assessment and monitoring. Naltrexone is generally considered only after a person is adequately free of opioids.

There is no universally best alternative. A clinician should compare expected benefit, safety, access, previous treatment experience, and patient preference. Do not switch between treatments without a supervised plan, especially where opioids may be involved.

Common and Serious Side Effects

Possible side effects of oral naltrexone include nausea, abdominal discomfort, headache, dizziness, tiredness, sleep disturbance, and reduced appetite. These effects may be mild for some people but should still be reported if persistent or troublesome. A pharmacist can discuss practical measures and when to contact the prescriber.

Less common but potentially serious concerns include liver-related symptoms such as unusual fatigue, dark urine, pale stools, persistent abdominal pain, or yellowing of the skin or eyes. These symptoms require prompt medical assessment. The risk-benefit decision is particularly important for people with existing liver disease or substantial alcohol-related liver injury.

Mood changes, severe anxiety, or thoughts of self-harm also warrant urgent clinical attention. Such symptoms may relate to many factors, including the underlying condition, but should never be dismissed. Contact emergency services or a crisis resource immediately if there is imminent risk of harm.

Who Should Not Take Revia

Revia should generally not be started in someone currently using opioids, experiencing opioid withdrawal, or with a positive opioid screen when clinically relevant. Starting too soon can precipitate intense withdrawal. This can be medically serious and requires urgent evaluation.

People with a known hypersensitivity to naltrexone or any tablet ingredient should not take the product. Those with acute hepatitis, significant liver impairment, or other serious medical conditions need individualized assessment. The prescriber may request baseline or follow-up liver testing where clinically appropriate.

Pregnancy, breastfeeding, kidney impairment, and mental-health history should be discussed before treatment. The available evidence and risks need to be weighed for the individual rather than assumed from general information. Patients should also disclose planned surgery or any possibility of needing opioid pain relief.

Age Limits and Other Restrictions

Use of naltrexone in children and adolescents requires specialist clinical judgement because evidence, approved indications, and product information may differ from adult care. A parent or guardian should not obtain or administer this medicine for a minor without an appropriate prescription and medical oversight. The pharmacy will dispense only according to lawful prescribing requirements.

Older adults may need additional review because of liver function, kidney function, multiple medicines, and fall risk from dizziness. Age alone does not determine suitability. A prescriber can assess the overall clinical picture and arrange monitoring when needed.

Patients should avoid driving, operating machinery, or performing hazardous tasks until they know how Revia affects them. Dizziness or fatigue can impair safe performance in some individuals. Alcohol, other medicines, sleep deprivation, and illness can further affect alertness.

Allergic Reactions and Alcohol Considerations

Signs of a possible allergic reaction include rash, hives, swelling of the face or throat, wheezing, or difficulty breathing. Severe symptoms require emergency medical care immediately. Do not take another dose until a clinician has assessed the reaction.

Revia does not usually cause the sudden flushing and severe illness reaction associated with alcohol-deterrent therapy. Nevertheless, alcohol can still impair judgement, worsen health conditions, interact with other medicines, and undermine recovery goals. The medicine should not be used as a reason to assume drinking is safe.

Discuss alcohol goals openly with the prescriber, including whether the aim is abstinence, reduction, or relapse prevention. A treatment plan can include coping strategies for high-risk situations and follow-up support. If alcohol withdrawal is possible, obtain medical guidance before abruptly stopping heavy drinking.

Overdose, Emergencies, and Safe Storage

Taking more Revia than prescribed may increase the risk of side effects and requires prompt advice from a poison centre, pharmacist, or healthcare professional. If there is collapse, seizure, breathing difficulty, severe confusion, or suspected opioid poisoning, call emergency services immediately. Do not wait for symptoms to worsen.

Keep tablets in their original container, tightly closed, and stored at the temperature stated on the pharmacy label or manufacturer packaging. Protect the medicine from excessive heat, moisture, and access by children, visitors, and pets. Do not use tablets that are damaged, expired, or stored outside recommended conditions.

Unused or expired tablets should be returned to a pharmacy for safe disposal where services are available. Do not share Revia with another person, even if they have similar symptoms or recovery goals. Secure storage is especially important because accidental use by a person taking opioids could cause dangerous withdrawal.

Delivery, Tracking, and Ongoing Pharmacy Support

After a prescription is verified and the medicine is dispensed, eligible deliveries may receive shipment confirmation and package tracking information. Tracking availability depends on the delivery method and destination. Patients should use a private delivery address and monitor the shipment to reduce the chance of loss or exposure to unsuitable temperatures.

Online pharmacy services can offer convenience for prescription transfers, refill coordination, and access to pharmacist support without unnecessary travel. They do not replace urgent medical care, addiction services, or emergency assessment. Secure dispensing should always include prescription validation and a means to contact a licensed pharmacy professional.

Before completing a purchase, review the medicine name, strength, quantity, delivery details, and counselling information. Contact the pharmacy promptly if the received product differs from the prescribed item or appears damaged. Continued communication with the prescriber and pharmacist helps keep Revia treatment safe, informed, and appropriately monitored.

Frequently Asked Questions

Is Revia the same medicine as low-dose naltrexone (LDN)?

Revia contains naltrexone, but “low-dose naltrexone” describes an off-label dosing approach that differs from the approved use of standard naltrexone products. A Revia tablet should not be repurposed or dose-adjusted for LDN without direction from a qualified prescriber and pharmacist in Canada.

Can Revia be used for weight loss?

Revia by itself is not generally approved as a weight-loss medicine. Naltrexone is included with another active ingredient in certain weight-management treatments, but that is not interchangeable with taking Revia alone. Discuss weight concerns with a healthcare professional to identify an appropriate, supervised option.

Will Revia appear on a workplace drug test?

Naltrexone is not an opioid and is not usually a target on standard workplace drug panels. However, testing methods vary, and uncommon false-positive results have been reported with some assays. Tell the testing provider about Revia and provide pharmacy documentation if requested.

What should I tell a dentist, surgeon, or emergency clinician about Revia?

Tell every treating clinician that you take Revia, especially before dental work, surgery, or emergency care. It can reduce or block the effect of opioid-containing pain medicines, so the care team may need to plan pain control differently. Do not try to overcome this effect by taking extra opioid medicine.

Can Revia affect treatment for a cough, diarrhea, or cold?

Some cough and diarrhea products contain opioid-related ingredients that may not work as expected while taking Revia. Before choosing an over-the-counter remedy, ask a pharmacist to check the active ingredients and recommend an appropriate non-opioid option where suitable.

Can Revia be taken with antidepressants or anxiety medicines?

There is no single answer for every medicine or supplement. Many people may use naltrexone alongside mental-health treatment, but a prescriber or pharmacist should review the full medication list for interactions, overlapping effects, and the underlying condition being treated. Do not stop psychiatric medication abruptly because of a potential interaction concern.

Are herbal supplements compatible with Revia?

Herbal and natural health products can have meaningful effects even when they are sold without a prescription. Bring the product name, ingredients, and dose to a pharmacist for review, particularly if it may affect the liver, mood, sleep, or pain management.

What should I know about Revia during pregnancy or breastfeeding?

If you are pregnant, planning pregnancy, or breastfeeding, discuss Revia with the clinician overseeing your care. The decision requires an individual assessment of potential benefits, uncertainties, and the risks of untreated alcohol or opioid use disorder; do not discontinue treatment without clinical guidance.

Why might liver tests be reviewed during Revia treatment?

Naltrexone is processed by the liver, and clinicians may consider liver history and blood tests when deciding whether treatment is appropriate or monitoring it over time. Contact a healthcare professional promptly for possible liver-warning symptoms such as yellowing of the skin or eyes, dark urine, persistent upper-abdominal pain, or marked fatigue.

Pharmacist Review

The current Revia product-page content has been professionally reviewed for medication-information clarity, prescription safety, and alignment with pharmacy practice in Canada.

Review detail	Information
Reviewed by	Avery MacLeod, Doctor of Pharmacy (PharmD), Registered Pharmacist
Professional registration	OCP Registration No. 287654
Professional association	Ontario College of Pharmacists
Review date	8 March 2025

Revia is a prescription medicine containing naltrexone. Treatment suitability, dosing, opioid-free requirements, possible interactions, and monitoring needs should be assessed by the prescribing clinician and pharmacist for each patient.

Important: This material is provided for informational purposes only and does not replace consultation with a doctor or other qualified healthcare professional.

Pharmacy Location and Hours

For in-store assistance with Revia, visit our pharmacy at 777 Bay St, Unit C208, Toronto, ON M5G 2C8, Canada.

Days	Hours
Monday–Friday	9:00 a.m.–6:00 p.m.
Saturday	10:00 a.m.–5:00 p.m.
Sunday	11:00 a.m.–4:00 p.m.